COO Stock Overview
Develops, manufactures, and markets contact lens wearers. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
COO passed our risk checks.
The Cooper Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$99.08 |
| 52 Week High | US$112.38 |
| 52 Week Low | US$82.22 |
| Beta | 0.99 |
| 11 Month Change | -7.16% |
| 3 Month Change | 5.28% |
| 1 Year Change | 16.89% |
| 33 Year Change | 1.40% |
| 5 Year Change | 25.03% |
| Change since IPO | 1,184.56% |
Recent News & Updates
We Think Cooper Companies (NASDAQ:COO) Can Stay On Top Of Its Debt
Nov 17
The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15Recent updates
We Think Cooper Companies (NASDAQ:COO) Can Stay On Top Of Its Debt
Nov 17The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15The Cooper Companies: Still An Expensive Place
Aug 26Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03Shareholder Returns
| COO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -2.7% | -0.4% | -1.0% |
| 1Y | 16.9% | 20.3% | 30.3% |
Return vs Industry: COO underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: COO underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 3.9% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: COO has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: COO's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies, Inc. Fundamentals Summary
| COO fundamental statistics | |
|---|---|
| Market cap | US$19.73b |
| Earnings (TTM) | US$359.30m |
| Revenue (TTM) | US$3.80b |
54.9x
P/E Ratio5.2x
P/S RatioIs COO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COO income statement (TTM) | |
|---|---|
| Revenue | US$3.80b |
| Cost of Revenue | US$1.28b |
| Gross Profit | US$2.52b |
| Other Expenses | US$2.17b |
| Earnings | US$359.30m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Dec 05, 2024
| Earnings per share (EPS) | 1.80 |
| Gross Margin | 66.36% |
| Net Profit Margin | 9.45% |
| Debt/Equity Ratio | 33.2% |
How did COO perform over the long term?
See historical performance and comparison